Published in J Clin Microbiol on September 01, 1993
Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol (2011) 2.65
Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2003) 1.40
Imipenem stability in a predried susceptibility panel. J Clin Microbiol (1994) 1.23
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother (1998) 1.15
Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem. J Clin Microbiol (1997) 0.99
Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers. J Clin Microbiol (2015) 0.84
Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients. Iran J Public Health (2010) 0.78
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11
Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 7.10
Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother (1986) 3.87
Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 3.74
Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob Agents Chemother (1990) 3.32
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics. J Infect Dis (1986) 2.73
Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.52
Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 2.23
Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. J Clin Microbiol (1991) 2.16
Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother (1980) 2.01
Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis (1985) 2.00
False resistance to imipenem with a microdilution susceptibility testing system. J Clin Microbiol (1991) 1.94
Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob Agents Chemother (1990) 1.72
Review of the in vitro spectrum of activity of imipenem. Am J Med (1985) 1.65
Cloning and expression of the imipenem-hydrolyzing beta-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother (1988) 1.50
Diffusion of beta-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 1.40
Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion. J Antimicrob Chemother (1990) 1.35
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev Infect Dis (1988) 1.30
Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa. Rev Infect Dis (1988) 1.23
Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis (1988) 1.21
Penetration of beta-lactams through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother (1987) 1.12
Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin. Antimicrob Agents Chemother (1981) 1.01
Carbapenems: special properties contributing to their activity. Am J Med (1985) 0.86
Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens. J Antimicrob Chemother (1986) 0.81
In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins. Chemotherapy (1982) 0.79
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
The objective evaluation of dysmenorrhea therapy. Am J Obstet Gynecol (1980) 4.38
Large lung bullae in marijuana smokers. Thorax (2000) 3.70
Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med (1999) 2.87
A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent. Fertil Steril (1982) 2.80
The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol (1993) 2.25
Prevalence of faecal excretion of verocytotoxigenic Escherichia coli O157 in cattle in England and Wales. Vet Rec (2003) 2.22
Total parenteral nutrition at home: studies in patients surviving 4 months to 5 years. Gastroenterology (1976) 2.21
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J (1993) 1.86
Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 1.76
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J Infect Dis (2007) 1.70
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Relative affinities of all Escherichia coli aminoacyl-tRNAs for elongation factor Tu-GTP. J Biol Chem (1984) 1.62
Endemic giardiasis in New Hampshire: a case-control study of environmental risks. J Infect Dis (1993) 1.60
Antibiotic-resistant isolates of Streptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. J Infect Dis (1986) 1.60
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains. Antimicrob Agents Chemother (1988) 1.58
Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci (1978) 1.54
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54
Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother (1995) 1.52
Hemoglobin, methylene blue and oxygen interactions in human red cells. J Pharmacol Exp Ther (1972) 1.51
Risk factors for transmission of foot-and-mouth disease during an outbreak in southern England in 2007. Vet Rec (2011) 1.49
Diversity of Babesia infecting deer ticks (Ixodes dammini). Am J Trop Med Hyg (1998) 1.47
Faecal carriage of verocytotoxin-producing Escherichia coli O157 in cattle and sheep at slaughter in Great Britain. Vet Rec (2002) 1.46
Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study. Cancer J Sci Am (1997) 1.45
Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med (1992) 1.45
Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol (2001) 1.43
Hydrogen sulfide poisoning. J Occup Med (1979) 1.43
Kinetic studies of Escherichia coli elongation factor Tu-guanosine 5'-triphosphate-aminoacyl-tRNA complexes. Biochemistry (1985) 1.41
Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med (1997) 1.39
Medical preparation for travel in Africa. J Natl Med Assoc (1982) 1.39
The effects of chemotactic factors on the adhesiveness of rabbit neutrophil granulocytes. Exp Cell Res (1979) 1.38
Precipitation in Manchester: ketorolac/cyclizine. Anaesthesia (2001) 1.38
Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun (1994) 1.37
Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr (1977) 1.36
Current concepts about the treatment of selected poisonings: nitrite, cyanide, sulfide, barium, and quinidine. Annu Rev Pharmacol Toxicol (1976) 1.31
Participation of birds (Aves) in the emergence of Lyme disease in southern Maine. J Med Entomol (1998) 1.30
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. J Antimicrob Chemother (1989) 1.30
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci U S A (1993) 1.29
Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. Am Rev Respir Dis (1988) 1.25
Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations. J Lab Clin Med (1981) 1.24
Immunohistochemical, electron microscopic and in situ hybridization evidence for the involvement of lymphatics in the spread of HIV-1. AIDS (1988) 1.24
Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. J Biol Chem (1993) 1.24
Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. Pediatr Infect Dis J (1993) 1.23
Canine seroprevalence and the distribution of Ixodes dammini in an area of emerging Lyme disease. Am J Public Health (1991) 1.21
Management of acute sulfide poisoning. Effects of oxygen, thiosulfate, and nitrite. Arch Environ Health (1976) 1.20
Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinology (2007) 1.20
The tolerance of coffee drinkers to caffeine. Clin Pharmacol Ther (1968) 1.18
Drug-induced methemoglobinemia. Semin Hematol (1973) 1.16
Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. J Lab Clin Med (1981) 1.15
Pseudomonas aeruginosa bacteremia: susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance. J Lab Clin Med (1979) 1.15
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother (1998) 1.15
In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents. J Antimicrob Chemother (1993) 1.15
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. J Clin Oncol (1993) 1.14
Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia. Antimicrob Agents Chemother (2011) 1.13
Nitroprusside produces cyanide poisoning via reaction with hemoglobin. J Pharmacol Exp Ther (1974) 1.12
Experimental superficial siderosis of the central nervous system: biochemical correlates. J Neurol Sci (1992) 1.12
Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. J Antimicrob Chemother (1994) 1.10
Impact of short-course quinolone therapy on susceptible and resistant populations of Staphylococcus aureus. J Infect Dis (2009) 1.10
Blue in the face. J Am Acad Dermatol (2001) 1.08
Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay. Infect Control Hosp Epidemiol (1997) 1.07
Risk factors for endemic giardiasis. Am J Public Health (1987) 1.07
Post-coital contraception using d1-norgestrel/ethinyl estradiol combination. Contraception (1978) 1.05
The effect of ageing on the disposition of nifedipine and atenolol. Br J Clin Pharmacol (1988) 1.04
Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infect Control Hosp Epidemiol (1994) 1.04
Assessing gravimetric estimation of intraoperative blood loss. J Gynecol Surg (1993) 1.04
The effect of methemoglobin on the inhibition of cytochrome c oxidase by cyanide, sulfide or azide. Biochem Pharmacol (1977) 1.02
Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets. Antimicrob Agents Chemother (2011) 1.02
Intestinal carriage of verocytotoxigenic Escherichia coli O157, Salmonella, thermophilic Campylobacter and Yersinia enterocolitica, in cattle, sheep and pigs at slaughter in Great Britain during 2003. Epidemiol Infect (2007) 1.01
Secondary syphilitic uveitis. Am J Ophthalmol (1981) 1.00
Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry (1992) 0.99
Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax (1996) 0.99
Relation of induced tinnitus to physical characteristics of the inducing stimuli. J Acoust Soc Am (1967) 0.99
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates. J Antimicrob Chemother (1986) 0.97
Transfusion-acquired babesiosis and failure of antibiotic treatment. JAMA (1986) 0.96
Sensory motor neuropathy associated with AIDS. Neurology (1988) 0.96
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents. J Antimicrob Chemother (1991) 0.96